Masitinib with riluzole for treating amyotrophic lateral sclerosis ID6257Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sodium phenylbutyrate–ursodoxicoltaurine for treating amyotrophic lateral sclerosis [ID6246]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Amyotrophic lateral sclerosis - SAR443820 TS ID 11938Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC